Hemostasis Valve Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||921978|
|出版日期||內容資訊||英文 111 Pages
|止血口才的全球市場:成長率，趨勢及預測 Hemostasis Valve Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年01月01日||內容資訊: 英文 111 Pages||
The significant factor attributing this market's growth is the increasing number of interventional procedures and surgical procedures worldwide. The rising pool of patients with different illnesses and rising demand for intensive hemostasis devices is also fuelling the market growth. Heart disease is the world's major cause of death and accounted for 17.9 million fatalities in 2016, according to the WHO (WORLD HEALTH ORGANIZATION) published data. Worldwide, the growth of the geriatric population has led to increased cardiovascular disease prevalence. Since 2011, the medical devices industry has seen an annual growth rate of around 4.5 percent. Rising occurrences of cardiovascular illnesses and an increase in the aging population have a significant impact on the growth of the market for the Hemostasis valve.
Hemostasis valves enable medical providers by giving them flexibility in catheters and delivery systems of the next generation. If a catheter is inserted into a body for angiography or other applications, the hemostasis valve is the device that avoids blood reflux.
Hospitals are Expected to Hold the Largest Market Share in the Hemostasis Valve Market
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall Hemostasis Valve market, throughout the forecast period. This is owing to factors like the rising prevalence of chronic disorders such as infectious diseases and the geriatric population. The cardiovascular disease stays the major cause of fatalities in the US, which in 2016 resulted in 840,768 fatalities (635,260 cardiac). Between 2006 and 2016, the death rate from CVD in the United States declined by 18.6% and 31.8% from coronary heart disease, according to the American College of Cardiology Foundation, Feb 2019. Coronary events are expected to occur in the United States in 2019 in around 1,055,000 Americans, along with 335,000 reoccurring and 720,000 new coronary incidents which are further expected to upsurge the demand of hemostasis devices in the market during the forecast period owing to the growth in the number of cardiac surgery.
The Hemostasis Valve market is moderately competitive and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and new product launches with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Boston Scientific Corporation, Merit Medical Systems, Teleflex Incorporated, Terumo Corporation, and Freudenberg Medical.